There are no ongoing discussions regarding an acquisition, nor any indications that the 2021 conversations will be rekindled.
In light of regulatory hurdles, sources told Bloomberg that little market overlap makes the two companies a match to face limited resistance. However, Cigna likely would need to scale back its portfolio to close the deal.
Should acquisition talks resume, it could be the largest deal in the industry. The only two deals of similar scale would be Anthem’s attempted $48 billion purchase of Cigna and Aetna’s proposed $35 billion deal to buy Humana — both of which were blocked by antitrust regulators, according to Bloomberg.
The acquisition would give Cigna more access to government-sponsored markets, in which Centene is highly competitive.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
